Long-term survival of anti-tumor lymphocytes generated by vaccination of patients with melanoma with a peptide vaccine

Journal of Immunotherapy

Volumn 23, Issue 4, 2000, Pages 401-404

  Stewart IV, John H ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

G209 2M; Melanoma

Indexed keywords

MELANOMA VACCINE;

ARTICLE; CANCER IMMUNOTHERAPY; CELL SURVIVAL; CLINICAL ARTICLE; HUMAN; LYMPHOCYTE; MELANOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION;

ANTINEOPLASTIC AGENTS; CANCER VACCINES; CELL SURVIVAL; COMBINED MODALITY THERAPY; FREUND'S ADJUVANT; HUMANS; INTERFERON TYPE II; LIPIDS; MELANOMA; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033934223     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200007000-00002     Document Type: Article

References (13)

1. Rosenberg SA, Yung JC, Schwartzentruber DJ, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 1998;4: 321-7.
2. Sprent J. Immunologic memory. Immunologist 1995;3:212-15.
3. Sprent J. Immunological memory. Curr Opin Immunol 1997;9: 371-9.
4. Bruno L, Kirberg J, von Boehmer H. On the cellular basis of immunologic memory. Immunity 1995;2:37-43.
5. Pihlgren M, Dubois PM, Tomkowiak M, Sjogren T, Marvel J. Resting memory CD 8+ T cells are hyperreactive to antigenic challenge in vitro. J Exp Med 1996;184:2141-51.
6. Sprent J, Miller JFAP. Fate of H2-activated T lymphocytes in syngeneic hosts. III. Differential in long-lived recirculating memory cells. Cell Immunol 1976;21:314-26.
7. Rotstein S, Blomgren H, Petrini B, Wasserman J, Baral E. Long-term effects on the immune system following local radiation therapy for breast cancer. 4. Proliferative responses and induction of suppressor activity of the blood lymphocyte population. Radiother Oncol 1986;6:223-30.
8. Berger M, Irschick E, Fritsch E, et al. Influence of local radiotherapy of breast cancer patients on the frequency of cytotoxic T lymphocyte precursor cells. Immunobiology 1990;180:261-71.
9. Monti G, Guerrini L, Magni E, Cruciani G, Bardella D. The mid-term effects of radiotherapy on T and B lymphocytes: an evaluation of cellular immunity with standard methods and monoclonal antibodies. Tumori 1984;70:335-8.
10. Lee P, Yee C, Savage P, et al. Characterization of circulating T cells specific for tumor associated antigens antigens in melanoma patients. Nat Med 1999;5:677-85.
11. Wasserman J, Blomgren H, Petrini B, et al. The effect of radiation therapy and in vitro X-ray exposure on lymphocyte subpopulations and their functions. Am J Clin Oncol 1982;5:195-208.
12. Rotstein S, Blomgren H, Petrini B, Wasserman J, Baral E. Long-term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte population. Int J Radiat Oncol Biol Phys 1985; 11:921-7.
13. Tisch M, Heimlich F, Daniel V, Opelz G, Maier H. Cellular immune defect caused by postsurgical radiation therapy in patients with head and neck cancer. Otolaryngol Head Neck Surg 1998; 119:412-17.